NASDAQ:ACHC - Acadia Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $39.33
  • Forecasted Upside: -6.08 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$41.88
▼ -0.4 (-0.95%)
1 month | 3 months | 12 months
Get New Acadia Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACHC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$39.33
▼ -6.08% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Acadia Healthcare in the last 3 months. The average price target is $39.33, with a high forecast of $54.00 and a low forecast of $30.00. The average price target represents a -6.08% upside from the last price of $41.88.
Buy
The current consensus among 9 polled investment analysts is to buy stock in Acadia Healthcare. This rating has held steady since July 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/12/2019
  • 1 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/10/2019
  • 1 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/9/2019
  • 1 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/8/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/6/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/4/2020
  • 1 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/3/2020
  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/3/2020

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/17/2020UBS GroupUpgradeNeutral ➝ Buy$37.00 ➝ $54.00Medium
i
11/2/2020StephensBoost Price TargetPositive ➝ Equal Weight$33.00 ➝ $42.00Medium
i
11/2/2020Credit Suisse GroupBoost Price TargetNeutral$32.00 ➝ $36.00Low
i
11/2/2020MizuhoBoost Price TargetBuy$31.00 ➝ $35.00Low
i
11/2/2020Royal Bank of CanadaBoost Price TargetOutperform$37.00 ➝ $42.00Low
i
9/30/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$40.00 ➝ $48.00Low
i
9/11/2020Raymond JamesReiterated RatingBuyLow
i
8/6/2020Credit Suisse GroupBoost Price TargetNeutral$28.00 ➝ $32.00Low
i
8/6/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$28.00 ➝ $32.00Low
i
8/6/2020MizuhoBoost Price TargetNeutral$26.00 ➝ $31.00Low
i
5/7/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$32.00 ➝ $28.00Medium
i
5/6/2020Robert W. BairdLower Price TargetNeutral$36.00 ➝ $30.00High
i
5/6/2020Credit Suisse GroupLower Price TargetNeutral$33.00 ➝ $28.00High
i
5/6/2020MizuhoBoost Price TargetNeutral$24.00 ➝ $26.00High
i
5/6/2020Raymond JamesLower Price TargetOutperform$40.00 ➝ $35.00High
i
5/5/2020Wells Fargo & CompanyReiterated RatingHoldHigh
i
Rating by Peter Costa at Wells Fargo & Company
1/28/2020StephensInitiated CoverageEqual Weight$36.00Low
i
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$27.00Low
i
12/11/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$37.00 ➝ $35.00Medium
i
10/10/2019Jefferies Financial GroupSet Price TargetBuy$40.00Low
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
9/20/2019UBS GroupBoost Price TargetNeutral$29.00 ➝ $34.00Medium
i
9/6/2019UBS GroupLower Price TargetNeutral$30.00 ➝ $29.00N/A
i
7/31/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$45.00High
i
5/31/2019MizuhoSet Price TargetHold$30.00Medium
i
Rating by Ann Hynes at Mizuho
5/2/2019Deutsche Bank AktiengesellschaftSet Price TargetHold$32.00Low
i
Rating by Pito Chickering at Deutsche Bank Aktiengesellschaft
5/1/2019BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$33.00 ➝ $36.00High
i
3/4/2019Robert W. BairdLower Price TargetNeutral ➝ Neutral$40.00 ➝ $38.00Low
i
3/4/2019CitigroupLower Price TargetBuy ➝ Buy$43.00 ➝ $38.00Low
i
1/25/2019MizuhoSet Price TargetHold$30.00Low
i
Rating by Ann Hynes at Mizuho
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$27.00Medium
i
11/26/2018Jefferies Financial GroupReiterated RatingBuy$42.00Low
i
11/16/2018Cantor FitzgeraldReiterated RatingHold$39.00High
i
11/15/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$39.00High
i
11/14/2018CitigroupLower Price TargetBuy ➝ Buy$46.00 ➝ $43.00Low
i
10/18/2018MizuhoSet Price TargetHold$37.00Low
i
Rating by Ann Hynes at Mizuho
10/18/2018Cantor FitzgeraldReiterated RatingHold$39.00Medium
i
10/17/2018Craig HallumDowngradeBuy ➝ HoldLow
i
8/28/2018MizuhoSet Price TargetHold$37.00Low
i
Rating by Ann Hynes at Mizuho
8/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$45.00Medium
i
7/31/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$44.00 ➝ $47.00High
i
7/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$40.00 ➝ $44.00High
i
2/27/2018Royal Bank of CanadaReiterated RatingBuy$45.00Low
i
2/25/2018Cantor FitzgeraldUpgradeNeutral ➝ OverweightLow
i
Rating by J. France at Cantor Fitzgerald
2/23/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$40.00 ➝ $45.00Low
i
2/22/2018Robert W. BairdSet Price TargetNeutral ➝ Hold$37.00 ➝ $42.00High
i
Rating by Whit Mayo at Robert W. Baird
2/22/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$35.00 ➝ $40.00High
i
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$41.00Low
i
12/19/2017Jefferies Financial GroupSet Price TargetBuy$42.00Medium
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
12/15/2017Robert W. BairdReiterated RatingHold$37.00Medium
i
Rating by Whit Mayo at Robert W. Baird
11/2/2017Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$35.00N/A
i
10/30/2017MizuhoReiterated RatingBuy ➝ NeutralN/A
i
Rating by Ann Hynes at Mizuho
10/29/2017MizuhoDowngradeBuy ➝ Neutral$36.00N/A
i
Rating by Ann Hynes at Mizuho
10/26/2017BMO Capital MarketsLower Price TargetOutperform$52.00 ➝ $48.00N/A
i
10/26/2017Craig HallumReiterated RatingBuy$65.00 ➝ $41.00N/A
i
10/25/2017Jefferies Financial GroupSet Price TargetBuy$42.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/25/2017CitigroupLower Price TargetBuy$61.00 ➝ $44.00N/A
i
10/25/2017Bank of AmericaLower Price TargetBuy$60.00 ➝ $52.00N/A
i
10/25/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$60.00 ➝ $37.00N/A
i
10/25/2017Robert W. BairdDowngradeOutperform ➝ Neutral$55.00 ➝ $38.00N/A
i
10/24/2017MizuhoSet Price TargetBuy$60.00N/A
i
Rating by Ann Hynes at Mizuho
10/24/2017Cantor FitzgeraldLower Price TargetNeutral$48.00 ➝ $39.00N/A
i
10/20/2017KeyCorpReiterated RatingBuy$59.00N/A
i
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$52.00N/A
i
10/11/2017Jefferies Financial GroupSet Price TargetBuy$60.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
7/31/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$58.00 ➝ $60.00Low
i
7/31/2017Craig HallumReiterated RatingBuy$52.00 ➝ $65.00Low
i
7/31/2017UBS GroupReiterated RatingBuy ➝ Positive$54.00 ➝ $60.00Low
i
7/28/2017MizuhoBoost Price TargetBuy$57.00 ➝ $60.00Low
i
7/18/2017William BlairInitiated CoverageOutperform ➝ OutperformLow
i
Rating by R. Daniels at William Blair
6/1/2017KeyCorpReiterated RatingOverweight$51.00Low
i
6/1/2017Jefferies Financial GroupSet Price TargetBuy$55.00Low
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
5/15/2017Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
5/15/2017SVB LeerinkDowngradeOutperform ➝ Market PerformMedium
i
Rating by A. Gupte at SVB Leerink LLC
5/5/2017Jefferies Financial GroupReiterated RatingBuyLow
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
4/26/2017Cantor FitzgeraldReiterated RatingHold$45.00High
i
Rating by J. France at Cantor Fitzgerald
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$53.00High
i
3/24/2017Cantor FitzgeraldReiterated RatingHold$45.00Low
i
Rating by J. France at Cantor Fitzgerald
3/6/2017CitigroupBoost Price TargetBuy$43.00 ➝ $52.00N/A
i
2/27/2017Cantor FitzgeraldReiterated RatingNeutral$45.00N/A
i
Rating by J. France at Cantor Fitzgerald
2/27/2017MizuhoReiterated RatingBuy ➝ Buy$45.00 ➝ $52.00N/A
i
1/27/2017Cantor FitzgeraldDowngradeOverweight ➝ Neutral$60.00 ➝ $45.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
1/11/2017KeyCorpLower Price TargetOverweight$58.00 ➝ $52.00N/A
i
1/4/2017CitigroupInitiated CoverageBuy$43.00N/A
i
1/3/2017Royal Bank of CanadaReiterated RatingBuy$56.00N/A
i
12/20/2016Jefferies Financial GroupSet Price TargetBuy$55.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
12/15/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
12/2/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
11/3/2016Raymond JamesUpgradeOutperform ➝ Strong-Buy$65.00N/A
i
11/3/2016UBS GroupUpgradeOutperform ➝ Strong-BuyN/A
i
Rating by A.J. Rice at UBS Group AG
11/3/2016MizuhoLower Price TargetBuy$71.00 ➝ $45.00N/A
i
11/2/2016Cantor FitzgeraldReiterated RatingBuy$60.00N/A
i
10/21/2016Royal Bank of CanadaReiterated RatingOutperform$78.00 ➝ $59.00N/A
i
10/19/2016UBS GroupLower Price TargetBuy$79.00 ➝ $55.00N/A
i
Rating by a.j. rice at UBS Group AG
10/19/2016Royal Bank of CanadaLower Price TargetOutperform$78.00 ➝ $59.00N/A
i
9/27/2016JPMorgan Chase & Co.Reiterated RatingHold$61.00N/A
i
9/26/2016SVB LeerinkReiterated RatingOutperform$80.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
9/22/2016UBS GroupSet Price TargetBuy$79.00N/A
i
Rating by a.j. rice at UBS Group AG
9/15/2016Robert W. BairdLower Price TargetOutperform$67.00 ➝ $66.00N/A
i
Rating by Whit Mayo at Robert W. Baird
8/28/2016SVB LeerinkReiterated RatingBuy$80.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
8/1/2016Royal Bank of CanadaReiterated RatingOutperform$86.00 ➝ $78.00N/A
i
8/1/2016Royal Bank of CanadaLower Price TargetOutperform$86.00 ➝ $78.00N/A
i
7/26/2016UBS GroupReiterated RatingBuy$85.00N/A
i
7/18/2016UBS GroupReiterated RatingBuy$85.00N/A
i
7/17/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
7/15/2016SVB LeerinkReiterated RatingOutperform$90.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
6/27/2016Jefferies Financial GroupReiterated RatingBuy$85.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
6/14/2016Robert W. BairdReiterated RatingOutperform$69.00N/A
i
Rating by Whit Mayo at Robert W. Baird
5/16/2016Robert W. BairdReiterated RatingBuyN/A
i
Rating by Whit Mayo at Robert W. Baird
5/5/2016Jefferies Financial GroupReiterated RatingBuy$85.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
5/2/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Ana Gupte at SVB Leerink LLC
4/29/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
4/29/2016MizuhoBoost Price TargetBuy$66.00 ➝ $71.00N/A
i
3/22/2016Jefferies Financial GroupReiterated RatingBuy$85.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
2/21/2016MizuhoReiterated RatingBuy$92.00N/A
i
2/20/2016StephensReiterated RatingBuyN/A
i
Rating by Sahar Wolff at Stephens
2/18/2016Cantor FitzgeraldReiterated RatingBuy$100.00N/A
i
2/18/2016140166Lower Price TargetPositive$92.00 ➝ $75.00N/A
i
2/18/2016Raymond JamesLower Price Target$80.00 ➝ $75.00N/A
i
2/18/2016Craig HallumLower Price TargetBuy$100.00 ➝ $85.00N/A
i
2/17/2016Avondale PartnersLower Price TargetMarket Outperform$90.00 ➝ $71.00N/A
i
2/17/2016Jefferies Financial GroupReiterated RatingBuy$100.00 ➝ $85.00N/A
i
2/1/2016KeyCorpInitiated CoverageOverweight$85.00N/A
i
1/11/2016Jefferies Financial GroupReiterated RatingTop Pick$100.00N/A
i
1/7/2016UBS GroupReiterated RatingBuy$80.00 ➝ $85.00N/A
i
(Data available from 12/3/2015 forward)
Acadia Healthcare logo
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides mental health rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult care services; and care first services for employees. As of December 31, 2019, the company operated a network of 585 behavioral healthcare facilities with 18,200 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $41.88
$41.70
$43.43

50 Day Range

MA: $37.89
$28.97
$43.85

52 Week Range

Now: $41.88
$11.09
$44.75

Volume

584,106 shs

Average Volume

729,508 shs

Market Capitalization

$3.73 billion

P/E Ratio

37.06

Dividend Yield

N/A

Beta

1.47